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 Abstract 
 
Introduction: The aim of this study was to compare the therapeutic and adverse effects of 
haloperidol to the combination of haloperidol and promethazine (antipsychotic + antihistamine) for 
controlling patients with aggressive or violent behavior referred to psychiatric emergency rooms.  
Methods: Using a double-blind randomized controlled trial, 100 eligible psychiatric patients 
admitted to emergency room of Taleghani hospital, Tehran, Iran, randomly received intramuscular 
haloperidol or haloperidol plus promethazine. The patients were observed at 20, 40, 60, 120 minute 
intervals and then at 6, 12 and 24 hourly intervals to determine if they were tranquil or asleep, need 
for further injection, serious adverse effects, acute dystonia, akathisia, need for other medications, 
and need for admission to hospital based on clinical judgment.  
Results: The mean age of patients was 36.25 years and 69% were male. Patients receiving 
promethazine plus haloperidol were more tranquil after 2, 6 and 12 hours and sustained sleep after 
hours 2 and 6. Adding promethazine to haloperidol decreased the need for repeated involvement of 
the psychiatrist on duty, using additional medications and hospital admission. Patients taking the 
combination of haloperidol and promethazine did not experience more adverse effects than those 
taking only haloperidol. 
Conclusion: The combination of haloperidol plus promethazine can be safely used in emergency 
rooms for controlling patient with agitation and aggressive behavior resulting in a sustained 
tranquilization or asleep and lower need for further intervention.  
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     Introduction  
     Aggressive and violent behavior is a common 
reason for referral to psychiatric emergency 
rooms and occurs in 1-3% of psychiatric patients 
(1,2). Such behavior could result from psychotic 
states especially auditory hallucinations and 
paranoid delusions, impulsivity, intoxication, 
cognitive impairment or a combination of these 
conditions. Aggressive behavior is possibly the 
most challenging part of management of these  
 
 
patients considering their vulnerability for agitation 
and violent reactions. It could be verbal or non-
verbal and influenced by patients’ anger, 
personality characteristics and emotional stressors 
such as forced hospitalization. However, the way 
those patients react and express their emotions 
have been overestimated and amended (3). The 
most common medications for management of 
agitation and aggressive behavior in the emergency 
settings around the world are antipsychotics, 
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benzodiazepines or a combination of both (4,5). 
The newer antipsychotics are the long acting 
agents like flupenthixol acetate and intramuscular 
olanzapin and ziprasidone (6, 7, 8). Evidences 
indicate that irritability, impulsivity, hyperactivity 
and agitation respond well to short-term treatment 
with dopamine antagonists. Among these, the 
least sedating and the more efficient (like haloperidol) 
are preferred on sedative agents. 
The combination of haloperidol and promethazine 
is a very common method for to quickly calm 
aggressive patients (9). Promethazine, a drug 
derived from phenothiazine, blocks histamine 
receptors, which increases sedation and may 
prevent dystonic adverse effect of the injected 
haloperidol (10).  Previous studies have compared 
haloperidol plus promethazine to lorazepam (11), 
haloperidol plus midazolame (12) and haloperidol 
alone (13), haloperidol to flunitrazepam (14) as 
well as olanzapine (15) and have reported 
benefits and disadvantages for each regimen. The 
effect may differ because of variation of the 
primary reason of agitation (16). The effectiveness 
of rapid tranquillization with haloperidol has also 
been compared to other antipsychotics such as 
olanzapine and aripiprazole but the results are not 
conclusive (17- 19).  
To the best of our knowledge there has been no 
study in Iran aimed at comparing the effect of 
haloperidol to the combination of haloperidol and 
promethazine in psychiatric emergency room 
setting. Hence, this trial was designed to close the 
gap in clinical knowledge in the Iranian population. 
 
 
    Methods 
    The clinical study protocol was approved by 
the ethic committee of Ardabil University of 
Medical Sciences and was carried out according 
to the provisions of the Declaration of Helsinki. 
Informed written consent was obtained from the 
caregiver of the patients. The study sample 
included all of the patients aged 18-50 years old 
with aggressive or violent behavior admitted to 
the emergency room of Taleghani hospital, 
Tehran, Iran from October 2011 to June 2012. 
Patients who failed to follow up (because of early 
discharge from the hospital or death) were 
excluded from the study.  
Consecutive patients were divided to two groups 
based on randomly assigned numbers to receive 
intramuscular haloperidol or haloperidol plus 
promethazine based on double blind randomized 
clinical trial. The initial dose of haloperidol was 5 
mg in both groups, which was increased up to a 
total of 20 mg (in divided doses) when there was 
no response. Promethazine was started at 25 mg 
and could be increased to a total dose of 100 mg 
if needed. 
The psychiatrist on duty who was blind to the 
medication used for tranquilization, followed-up 
and observed patients at 20, 40, 60, 120 minute 
intervals and then at 6, 12 and 24 hourly intervals 
in terms of being tranquil or asleep, need for 
further injection, serious adverse effects such as 
acute dystonia, akathisia and delirium need for 
other medications and need for admission to 
hospital. The observations were recorded in a 
predefined case report form. Patients were 
considered to be tranquil when they were calm 
and without aggressive or dangerous behavior. 
The severity of symptoms was based on clinical 
judgment of the psychiatrist. 
Statistical significance was calculated with the 
chi-squared test for comparing proportions of 
patients tranquillized, asleep, requiring multiple 
visits of the psychiatrist, and requiring additional 
sedation, as appropriate. Data are expressed as the 
mean±SD and number (percentage). Statistical 
significance was defined as p<0.05.  
  
   
 Results  
   From the total of 128 patients admitted to the 
emergency room, follow-up data was available 
for 100 patients, including 50 patients receiving 
haloperidol alone, and 50 receiving haloperidol 
plus promethazine (figure 1). Characteristics of 
these patients are shown in table 1. Most of the 
patients were male (66%, 33/50) and the most 
common reason for referral was an acute mania 
or mixed episode. 
 
      
 
    
Abolhassanzadeh, Shafiee-Kandjani, Shafiei, Beiraghi 
 
International Journal of Applied Behavioral Sciences (IJABS) volume 2 number 2 Spring 2015. Journals. smbu.ac.ir/ijabs                   31 
 
 
Figure 1 - CONSORT Flow Diagram 
 
Table 1. Baseline clinical and demographic characteristics of patients with aggressive behavior in emergency room.  
 Haloperidol Haloperidol plus promethazine 
Male n (%) 33 (66) 36 (72) 
Female n (%) 17 (34) 14 (28) 
Mean age (SD) 35.98(14.00) 36.52(11.44) 
Previous admission    
         Yes n (%) 28 (48) 30 (52) 
         No n (%) 23 (55) 19 (45) 
Clinical diagnosis for aggression   
 Psychotic disorders  13 9 
 Substance misuse 0 4 
 Substance withdrawal disorder  3 9 
 Personality disorders 2 2 
 Bipolar mood disorder 24 18 
 Other* 8 8 
Severity of aggression    
 Moderate 31 21 
 Severe 16 21 
 Very severe 3 8 
 
 
Assessed for eligibility 
(n=128) 
Excluded (n=28) 
   Not meeting inclusion criteria (n=15  ) 
   Declined to participate (n=13  ) 
   Other reasons (n=0  ) 
Analysed (n=50) 
 Excluded from analysis (give reasons) (n= 0 ) 
Lost to follow-up (give reasons) (n= 0) 
Discontinued intervention (give reasons) (n=0) 
Allocated to intervention (n=50) 
 Received allocated intervention (n= 50 ) 
 Did not receive allocated intervention (give 
reasons) (n=0) 
Lost to follow-up (give reasons) (n= 0) 
Discontinued intervention (give reasons) (n=0) 
Allocated to intervention (n=50) 
 Received allocated intervention (n=50) 
 Did not receive allocated intervention (give 
reasons) (n= 0 ) 
Analysed (n=50) 
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Main outcomes for this trial are described in 
table 2. As shown, there was no significant 
difference between the two groups in terms of 
tranquility in minutes 20, 40, 60 or after 24 
hours, but patients receiving haloperidol plus 
promethazine were more tranquil at minutes 120 
as well as hours 6 and 12.  
Though equal numbers of patients from each 
group were asleep within one hour, the 
combination of haloperidol plus promethazine 
was superior to haloperidol alone in maintaining 
sleep at hours 2, 6 and 12 hours.  
Adding promethazine to haloperidol was not 
accompanied by an increase in adverse effects 
or further episodes of aggressive behavior or 
violence and an equal number of patients from 
both groups needed more injections to be 
tranquilized (table2). However, the antipsychotic -
antihistamine combination significantly reduced 
the need for repeated involvement of the 
psychiatrist on duty, using additional 
medications and hospital admission.  
 
Table 2. Main outcomes related to tranquility and asleep 
Tranquil  Haloperidol n(%) Haloperidol plus 
promethazine n(%) 
χ2 
 20 min 36 (33.0) 2 (33.0) 1.60 
 40 min 14 (42.0) 43 (42.0) 0.29 
 60 min 36 (28.0) 40 (38.0) 0.87 
 120 min 26 (32.5) 39 (32.5) 7.42 ** 
 6 hr 17 (26.2) 36 (26.8) 13.84 ** 
 12 hr 9 (16.0) 23 (16.0) 9.007 ** 
 24 hr 7 (9.0) 11 (9.0) 1.08 
Asleep  
 20 min 29 (29.0) 29 (29.0) 0.00 
 40 min 29 (31.0) 33 (31.3) 0.67 
 60 min 31 (32.5) 34 (32.5) 0.39 
 120 min 25 (30.0) 35 (30.0) 4.16 * 
 6 hr 17 (23.0) 29 (23.0) 5.76 ** 
 12 hr 3 (3.5) 4 (3.5) 0.15 
 24 hr 0 1 (0.5) 1.01 
 
Need for second injection 19 (17.0) 15 (17.0) 0.71 
Further Aggression within 24 hours 23 (19.5) 16 (19.5) 2.06 
Psychiatrist recalled 18 (13.5) 9 (13.5) 4.11 * 
Adverse effects 5 (6.5) 8 (6.5) 0.76 
Additional medication within 24 hours 31 (26.5) 22 (26.5) 3.25 * 
Admission more than 2 weeks 23(17.5) 12 (17.5) 5.31 * 
 
      Conclusion 
       This study compared the effect of 
haloperidol to the combination of haloperidol 
and promethazine in controlling aggressive 
behavior in emergency rooms. Results of the 
current study revealed that patients who 
received combination of haloperidol and 
promethazine were more tranquil in hours 2, 6 
and 12 after injection. Although few studies 
have achieved a better result comparatively in 
the first 20 minutes (13), results presented in 
this study are compatible with studies by 
Alexander et al. (11), Baldacara et al. (12) and 
Raveendran et al. (17) who also found a lengthy 
and superior effect for this combination. These 
studies attribute the superior performance to 
sedative effects of promethazine and its 
antimuscaranic properties as well as better 
safety profile in preventing serious adverse 
effects related to the extrapyramidal system. 
These results suggest that agitated patients may 
benefit from this combination to achieve a long-
standing effect, particularly in chaotic emergency 
room situations where on set and duration of 
medication efficacy is important for operational 
productivity. 
The same pattern was found for maintaining the 
sleep in patients receiving haloperidol and 
promethazine. The same number of patients was 
asleep from both groups during the first 60 
minutes as well as last hours of follow up, but 
sleep was better maintained in hours 2 and 6 
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after injection in patients receiving the 
combination. These results are compatible with 
previous studies (11-12, 16). Sedation by 
haloperidol is probably explained by blockage 
of dopamine transport in the brain. Haloperidol 
is structurally similar to transporter of gamma 
amino butyric acid (GABA) and interacts with 
GABA receptors in higher doses (20). Adding 
an antihistamine to haloperidol could reinforce 
this effect and induce more sedation than with 
haloperidol alone (9,10).  
We did not find higher instances of adverse 
effects for the combination. However, unlike 
some studies (13) the group receiving haloperidol 
alone did not have higher adverse effects (like 
dystonia). These results are not conclusive as 
they could be influenced by several factors such 
as age and medications taken by the patients. 
For example, side effects like dystonia are not 
usually expected in a patient who is already 
taking an antipsychotic and probably an 
anticholinergic as prophylactic agent for such 
adverse effect.  
Similar to previous studies, these results showed 
that the combination of haloperidol and 
promethazine decreased the need for repeated 
calling of the psychiatrist on duty, administration 
of additional medications such as chlorpromazine 
or lorazepam, and the need for hospitalization 
after hour 12, which is the normal course of 
action for patients not responding to the 
medication (11-15). These outcomes could in 
part be as a result of sustained sleep and being 
tranquil.  
Main outcomes including being asleep and 
tranquil, were measured as nominal variables 
and by clinical judgment according to criteria 
defined in the patient case report form. The 
reason for referral was not the same in all 
patients and could influence the efficacy of 
medication. Furthermore, studies are suggested 
to include patients with the same primary reason 
for aggressive behavior and standard scales. In 
conclusion, the combination of haloperidol plus 
promethazine can be safely used in emergency 
rooms for controlling patient with agitation and 
aggressive behavior resulting a sustained 
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